Medication

Wegovy or Mounjaro Before Surgery: What UK Anaesthetic Guidance Says

Wegovy and Mounjaro slow digestion, which matters under anaesthetic. What the MHRA and 2025 UK consensus guidance say about taking them before planned surgery.

4 min read
Wegovy or Mounjaro Before Surgery: What UK Anaesthetic Guidance Says

Wegovy or Mounjaro Before Surgery: What UK Anaesthetic Guidance Says

People taking Wegovy (semaglutide) or Mounjaro (tirzepatide) who need an operation often hear conflicting advice about whether to stop their injection. The concern is a rare but serious anaesthetic complication linked to how these medicines slow digestion. In 2025, the MHRA issued a safety update and UK anaesthetic and surgical bodies published joint guidance. This article explains the risk and what that guidance says.

What the evidence supports is that these medicines can leave food in the stomach for longer, even after normal fasting. Current UK guidance does not recommend routinely stopping them before planned surgery. Instead, it asks the anaesthetic team to assess each person and plan accordingly.

The short answer

UK consensus guidance published in 2025 says people taking GLP-1 or dual GIP/GLP-1 medicines should usually continue them around planned surgery, follow standard fasting instructions, and tell their surgical and anaesthetic team that they take them. The team then assesses the individual risk. Nobody should stop or change a dose before surgery without advice from the team looking after them.

Why these medicines matter for anaesthesia

Wegovy and Mounjaro slow gastric emptying, the rate at which food leaves the stomach. Under general anaesthesia or deep sedation, the reflexes that normally protect the airway are suppressed. If the stomach still contains food or fluid, there is a risk that it is brought up and breathed into the lungs, a complication called pulmonary aspiration. This can cause a serious chest infection or lung injury.

Normal pre-operative fasting is designed to make sure the stomach is empty. The concern with these medicines is that standard fasting times may not always be enough. Our medical overview of how weight loss medications work explains the effect on digestion in more detail.

What the MHRA has said

In a January 2025 Drug Safety Update, the MHRA reminded healthcare professionals that GLP-1 and dual GIP/GLP-1 receptor agonists delay gastric emptying, which may increase the risk of residual stomach contents despite fasting. It asked clinicians to ask patients directly whether they take these medicines and to take this into account when planning anaesthesia.

What the UK consensus guidance recommends

A multidisciplinary consensus statement, published in Anaesthesia in 2025 by the Association of Anaesthetists with the Centre for Perioperative Care and other UK bodies, set out the main recommendations for planned (elective) procedures in adults:

  • Continue the medicine throughout the peri-operative period in most cases, rather than stopping it.
  • Discuss the risk of aspiration and ways to reduce it with the patient, as a shared decision.
  • Follow standard fasting guidelines.
  • Do not rely on symptoms alone. The absence of nausea or fullness does not prove the stomach is empty.

The authors concluded that there was not enough evidence to set a definitive period for stopping these medicines before surgery. Stopping also has downsides, such as poorer glucose control in people with diabetes and a return of side effects when the medicine is restarted. The anaesthetic team may use other measures, chosen for the individual, to reduce risk on the day.

Guidance in other countries differs in some details, including advice on a liquid diet before procedures. People should follow the instructions given by their own UK hospital team.

What patients should do

  • Tell the pre-assessment team, surgeon and anaesthetist that you take Wegovy or Mounjaro, including if it was prescribed privately.
  • Mention the dose and when you last increased it, and any nausea, vomiting or bloating.
  • Follow the fasting and medicine instructions you are given exactly.
  • Do not stop, skip or change your injection on your own initiative.

People with type 2 diabetes may have separate instructions for other glucose-lowering medicines, such as SGLT2 inhibitors, which are usually paused around surgery.

After any procedure, persistent vomiting, severe abdominal pain or signs of dehydration should be reported to the hospital team or NHS 111 urgently. Suspected side effects can be reported through the MHRA Yellow Card scheme.

What remains unknown

  • How much the risk varies by dose, length of treatment or recent dose increases.
  • Which measures on the day of surgery work best.
  • How often aspiration actually occurs in people on these medicines; reported cases are rare, but the true rate is uncertain.

The bottom line

Wegovy and Mounjaro can delay stomach emptying enough to matter during anaesthesia, but UK guidance does not recommend routinely stopping them before planned surgery. The key step is making sure the surgical and anaesthetic team know about the medicine so they can plan safely. For broader safety context, see are weight loss medications safe? and speak to your GP, surgical team or regulated UK prescriber about your own situation.

Sources and further reading

  • El-Boghdadly K, et al. Elective peri-operative management of adults taking glucagon-like peptide-1 receptor agonists, glucose-dependent insulinotropic peptide agonists and sodium-glucose cotransporter-2 inhibitors: a multidisciplinary consensus statement. Anaesthesia. 2025;80(4):412–424.
  • MHRA Drug Safety Update: GLP-1 and dual GIP/GLP-1 receptor agonists: potential risk of pulmonary aspiration during general anaesthesia or deep sedation (January 2025)
  • Royal College of Anaesthetists: GLP-1 and dual GIP/GLP-1 receptor agonists: potential risk of pulmonary aspiration during general anaesthesia and deep sedation
  • Mounjaro (tirzepatide) SmPC (EMC)

Related reading from the Health Hub


Always speak to your GP or a regulated UK prescriber before starting, stopping or changing any medication. This article is for general information only and does not replace individual medical advice.

Get weekly weight loss tips

Join our newsletter for provider updates, expert guidance, and exclusive offers — no spam.

Subscribe free